Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Biogency Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (22)
ARTG (18)

Date

2026 (5)
2025 (9)
2024 (10)
2023 (7)
2022 (1)
2021 (5)
2020 (2)
2018 (1)

Search

Sponsor content

40 result(s) found, displaying 31 to 40

Biogency Women's Supplement Tablets (399651)

18 November 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biogency Women's Supplement Tablets.
Biogency Bonefits Tablets (378319)

19 November 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biogency Bonefits Tablets.
Biogency Cranberry Tablets Cancelled under Section 30(1)(c) of the Act

28 March 2023

Cancellation by sponsor

Requested by Biogency Pty Ltd
Biogency Synext Tablets (363307)

27 April 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biogency Synext Tablets.
Biogency Multi-B Capsules (362318)

16 April 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biogency Multi-B Capsules.
Biogency Piliant Tablets (352202)

23 December 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biogency Piliant Tablets.
Biogency Synext Lite Tablets (334453)

17 April 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Biogency Synext Lite Tablets.
Synext Tablets Cancelled under Section 30(1)(c) of the Act

5 March 2021

Cancellation by sponsor

Requested by Biogency Pty Ltd
Biogency Piliant Tablets Cancelled under Section 30(1)(c) of the Act

5 March 2021

Cancellation by sponsor

Requested by Biogency Pty Ltd
Synorigin Tablets Cancelled under Section 30(1)(c) of the Act

12 November 2018

Cancellation by sponsor

Requested by Biogency Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.